Skip to main content
. 2021 Oct 21;9:65. doi: 10.1186/s40560-021-00581-5

Fig. 3.

Fig. 3

Plasma TMAO concentrations in patients classified by A in-hospital death or survival to discharge and B cause of death during hospitalization. **p < 0.05, ***p < 0.001. TMAO trimethylamine-N-oxide; CAG coronary angiography; CV cardiovascular